NDAINTRAVENOUSSOLUTION
Approved
Apr 2014
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
14
Data completeness
3/8 — Basic
Drug data last refreshed Yesterday
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VASOSTRICT (vasopressin) is an intravenous solution approved in 2014 for the treatment of septic shock. It is a vasopressor agent that acts on V1 and V2 receptors to increase blood pressure and systemic vascular resistance in critically ill patients.
Peak8.7 years to LOE
Peak lifecycle product with strong patent protection through 2035; brand teams are focused on market penetration and maintaining share against generic and newer alternative vasopressors.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (14)
Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency
Started Sep 2025
40 enrolled
Vasopressin Deficiency
Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis
Started Nov 2024
2,800 enrolled
Septic Shock
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
Started Jun 2024
1,050 enrolled
TraumaHemorrhage
Intranasal Vasopressin Treatment in Children With Autism
Started Feb 2018
157 enrolled
AutismAutism Spectrum DisorderASD
The Effect of Vasopressin on Glucose Regulation
Started Apr 2016
60 enrolled
Insulin Resistance
Worked on VASOSTRICT at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.